Carlos Pérez-Guzmán serves as a Physician specialized in pulmonary medicine. He holds an M.S. degree in medical sciences. His areas of expertise include tuberculosis and drug resistant tuberculosis. Pérez-Guzmán is a Member of the National Academy of Medicine, Mexico. He works as a Pulmonary Specialist at Instituto Mexicano del Seguro Social, Mexico City, DF, Mexico, and the Leader of the State Drug Resistance Committee. His latest publications include the following: (1) Migliori GB et al., The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB, “Drug resistance beyond XDR-TB: results from a large individual patient data meta-analysis” (Eur Respir J., October 11, 2012); (2) Ahuja SD et al., The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB, “Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients” (PLoS Med., August 2012;9(8)); (3) Falzon D., The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB, “Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes” (Eur Respir J., October 25, 2012); (4) Pérez-Guzmán C, Vargas MH, Arellano-Macías Mdel R, Hernández-Cobos S, García-Ituarte AZ, and Serna-Vela FJ., “Clinical and epidemiological features of extrapulmonary tuberculosis in a high incidence region” (Salud Pública México, April 2014;56(2):189–96); (5) Pérez-Guzmán C, Vargas MH, Pérez-Arellano CP, and García-Toledo D., “Treating pyrazinamide mono-resistant pulmonary tuberculosis” (Int J Tuberc Lung Dis., September 2013;17(9):1244–5).
Biography Updated on 27 August 2014